XpresSpa Group, Inc. (XSPA) is an international leader in providing health and wellness services having three distinct brands: XpresCheck, XpresSpa, and Treat. The services provided by the company’s brands include providing on-site (airport) Covid-19 screening and testing, spa services at the airport, and on-demand healthcare access via technology.
XSPA stock price during the regular trading of March 15, 2022, roared by 7.7% to be $1.06. Its price further soared by 2.83% at the time of writing in the aftermarket session.
XSPA: Key Financials
On March 15, 2022, XSPA released its unaudited Q4 2021 financials for the quarter ended December 31, 2021. Some key updates are as follows.
Revenue
Total revenue was $29.4 million in Q4 2021 corresponding to $0.3 million in the corresponding quarter of 2020. Its revenue increased phenomenally by $29.1 million YoY.
EPS
Basic and diluted net income per share in Q4 2021 was $1.83 million or $0.03 in comparison to a net loss of $16.3 million or $0.22 in the corresponding period of 2020. The company’s EPS increased manifold yearly.
XSPA: Events and Happenings
On March 07, 2022, XSPA informed the press about the participation of Scott Milford, its CEO at the Fireside Chat Series of Water Tower Research on March 9, 2022. On February 22, 2022, XSPA announced the inauguration of a second testing facility for COVID-19 by its brand XpresCheck at Denver International Airport.
On January 31, 2022, XSPA reported along with the Centers for Disease Control and Prevention about the expansion of their preliminary $2 million biosurveillance facility. XpresCheck is providing biosurveillance services at the airports and the total worth of the agreement is $5.6 million.
Conclusion
XSPA stock is up to 47% bearish year-to-date mainly as an outcome of the pandemic constraints. Currently, its stock is showing a slight bullish behavior as the company reported record growth in its revenue over the year, along with a significant increase in EPS. For the first quarter of fiscal 2022, the company’s revenue expectations are $27.1 million versus earnings of $0.06 per share.
